[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medpace Holdings Inc (MEDP)

Medpace Holdings Inc (MEDP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,143,308
  • Shares Outstanding, K 28,560
  • Annual Sales, $ 2,530 M
  • Annual Income, $ 451,120 K
  • EBIT $ 591 M
  • EBITDA $ 619 M
  • 60-Month Beta 1.18
  • Price/Sales 5.16
  • Price/Cash Flow 26.87
  • Price/Book 21.82

Options Overview Details

View History
  • Implied Volatility 38.92% (+2.90%)
  • Historical Volatility 21.55%
  • IV Percentile 52%
  • IV Rank 30.03%
  • IV High 67.09% on 04/22/26
  • IV Low 26.83% on 08/15/25
  • Expected Move (DTE 27) 17.26 (3.75%)
  • Put/Call Vol Ratio 12.57
  • Today's Volume 570
  • Volume Avg (30-Day) 67
  • Put/Call OI Ratio 4.55
  • Today's Open Interest 3,756
  • Open Int (30-Day) 3,385
  • Expected Range 442.95 to 477.46

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $4.08
  • Number of Estimates 3
  • High Estimate $4.11
  • Low Estimate $4.03
  • Prior Year $3.10
  • Growth Rate Est. (year over year) +31.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
403.46 +14.06%
on 05/20/26
479.30 -3.98%
on 06/12/26
+39.53 (+9.40%)
since 05/18/26
3-Month
373.00 +23.38%
on 04/23/26
530.97 -13.33%
on 04/16/26
+5.40 (+1.19%)
since 03/18/26
52-Week
301.90 +52.43%
on 06/20/25
628.92 -26.83%
on 01/16/26
+157.51 (+52.04%)
since 06/18/25

Most Recent Stories

More News
Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026

Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2026 financial results after the market close on Wednesday, July 22, 2026. The Company will...

MEDP : 460.20 (+0.68%)
1 Profitable Stock to Consider Right Now and 2 We Brush Off

1 Profitable Stock to Consider Right Now and 2 We Brush Off

MEDP : 460.20 (+0.68%)
ROCK : 40.90 (+0.94%)
SGI : 75.10 (+1.39%)
Bronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK , June 8, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Medpace...

MEDP : 460.20 (+0.68%)
MEDP DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Medpace (MEDP) Investors of Securities Class Action Deadline on June 8, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their Options...

MEDP : 460.20 (+0.68%)
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Highlights Class Action Against Medpace Holdings (MEDP) and Upcoming Lead Plaintiff Deadline of June 8, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Medpace To Contact Him Directly To Discuss Their Options...

MEDP : 460.20 (+0.68%)
MONDAY INVESTOR DEADLINE: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - MEDP

SAN DIEGO , June 6, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Medpace Holdings Inc. (NASDAQ: MEDP) common stock between...

MEDP : 460.20 (+0.68%)
Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , June 5, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against...

MEDP : 460.20 (+0.68%)
MEDP Deadline: Rosen Law Firm Urges Medpace Holdings, Inc. (NASDAQ: MEDP) Stockholders to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of common stock of Medpace Holdings, Inc. (NASDAQ: MEDP) between April 22, 2025...

MEDP : 460.20 (+0.68%)
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES , June 5, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace"...

MEDP : 460.20 (+0.68%)
Medpace Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MEDP

LOS ANGELES , June 5, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Medpace Holdings, Inc. ("Medpace" or "the Company") (NASDAQ: MEDP ) for violations...

MEDP : 460.20 (+0.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

See More

Key Turning Points

3rd Resistance Point 481.77
2nd Resistance Point 472.55
1st Resistance Point 466.38
Last Price 460.20
1st Support Level 450.99
2nd Support Level 441.77
3rd Support Level 435.60

See More

52-Week High 628.92
Fibonacci 61.8% 504.00
Fibonacci 50% 465.41
Last Price 460.20
Fibonacci 38.2% 426.82
52-Week Low 301.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.